The administration of President Donald Trump revealed a plan on July 31 that would let Americans buy lower-cost prescription drugs from Canada.
The action plan (pdf) released by the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) included two pathways to get lower-cost drugs to consumers.